N-ethyl-N-methyl-1-pyridin-2-ylethanamine

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: N-ethyl-N-methyl-1-pyridin-2-ylethanamine
• 化学式: C₁₀H₁₆N₂
• 分子量: 164.25
• InChiKey: SQCUCLWIJANYEY-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.5
• 重原子数：
  12
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  16.1
• 氢给体数：
  0
• 氢受体数：
  2

文献信息

• COMPOUNDS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASE
  申请人：SHY Therapeutics LLC

  公开号：US20170174699A1

  公开（公告）日：2017-06-22

  Provided herein are compounds that inhibit the phosphorylation of MAPK and thus are useful in compositions and methods for treating cancer and inflammatory disease.

  本文提供了抑制MAPK磷酸化的化合物，因此可用于治疗癌症和炎症性疾病的组合物和方法。
• PYRIDONE COMPOUND, AND AGRICULTURAL AND HORTICULTURAL FUNGICIDE HAVING THIS AS ACTIVE COMPONENT
  申请人：Mitsui Chemicals Agro, Inc.

  公开号：EP3611164A1

  公开（公告）日：2020-02-19

  Novel compounds controlling plant diseases are provided. Pyridone compounds of the invention are novel and can control plant diseases. The pyridone compounds of the invention encompass compounds of formula (1) and salts thereof.

  本发明提供了控制植物病害的新型化合物。本发明的吡啶酮化合物很新颖，可以控制植物病害。本发明的吡啶酮化合物包括式（1）化合物及其盐类。
• Compounds for the treatment of cancer and inflammatory disease
  申请人：SHY Therapeutics LLC

  公开号：US10221191B2

  公开（公告）日：2019-03-05

  Provided herein are compounds that inhibit the phosphorylation of MAPK and thus are useful in compositions and methods for treating cancer and inflammatory disease.

  本文提供的化合物可抑制 MAPK 磷酸化，因此可用于治疗癌症和炎症性疾病的组合物和方法中。
• Vanadium Containing Hydrosilylation Catalysts And Compositions Containing The Catalysts
  申请人：Dow Corning Corporation

  公开号：US20140200348A1

  公开（公告）日：2014-07-17

  A composition contains (A) a hydrosilylation reaction catalyst and (B) an aliphatically unsaturated compound having an average, per molecule, of one or more aliphatically unsaturated organic groups capable of undergoing hydrosilylation reaction. The composition capable of reacting via hydrosilylation reaction to form a reaction product, such as a silane, a gum, a gel, a rubber, or a resin. Ingredient (A) contains a metal-ligand complex that can be prepared by a method including reacting a metal precursor and a ligand.
• [EN] COMPOUNDS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASE<br/>[FR] COMPOSÉS POUR LE TRAITEMENT DU CANCER ET DE MALADIES INFLAMMATOIRES
  申请人：SHY THERAPEUTICS LLC

  公开号：WO2017112777A1

  公开（公告）日：2017-06-29

  Provided herein are compounds that inhibit the phosphorylation of MAPK and thus are compositions and methods for treating cancer and inflammatory disease.